In addition to this study, Proscia plans to conduct additional research illustrating the potential benefits of AI in helping pathologists to diagnose melanoma, including lowering the misdiagnosis rate, accelerating turnaround times for critical results, reducing costs and distress for patients.
Featured Story:
Latest Articles
October 1, 2024